Parkside Financial Bank & Trust’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
VPM
VCM
EC
Parkside Financial Bank & Trust's JAZZ Position: Q1 2026 in Review
Parkside Financial Bank & Trust held its Jazz Pharmaceuticals (JAZZ) position steady in Q1 2026 at 237 shares worth $44.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1000.
Parkside Financial Bank & Trust first reported a position in JAZZ in Q1 2019 and has held it in 29 quarters since. 572 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.
- Parkside Financial Bank & Trust held 237 shares of Jazz Pharmaceuticals worth $44.8K as of Q1 2026.
- Parkside Financial Bank & Trust left its Jazz Pharmaceuticals share count unchanged in Q1 2026.
- Jazz Pharmaceuticals made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #1000 holding.
- Parkside Financial Bank & Trust first reported a position in Jazz Pharmaceuticals in Q1 2019 and has held it in 29 quarters since.
- 572 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.
Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.